US Senator Lummis: Plans to push the CLARITY Act into review in May; bitcoin is true free currency
Foresight News reports that Cynthia Lummis, U.S. Senator from Wyoming and Chair of the Senate Digital Assets Banking Subcommittee, stated at the "Bitcoin 2026" conference that she plans to advance the CLARITY Act into the review process this May and will work to have the bill ultimately enacted, establishing a comprehensive regulatory framework for the U.S. crypto market. She also shared her introduction to Bitcoin: between 2013 and 2014, she purchased three bitcoins at $300 each, and subsequently became one of the earliest senators to systematically promote crypto legislation during her Senate term. Bitcoin’s design, which does not rely on a trusted third party and limits the total supply to 21 million, makes it a true "free currency" in her view, and she believes the U.S. should become the global hub for this asset.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation

Forge Nano completes acquisition of HzO
